Company: SNPS
Filing Date: 2025-02-26
Form Type: 10-Q
Source: 0000883241-25-000014
Chunk: 135

Company: SYNOPSYS INC
Filing Date: 2025-02-26
Form: 10-Q
Item: Item 8
Chunk 135
---
 securities109,596 314 (96)— 109,814 Asset-backed securities27,210 112 (3)(15)27,304 Total:$155,160 $447 $(103)$(15)$155,489 (1)See Note 9. Fair Value Measurements for further discussion on fair values.The contractual maturities of our available-for-sale debt securities as of January 31, 2025 are as follows:Amortized CostFair Value(in thousands)1 year or less$65,977 $66,158 1-5 years84,803 84,943 5-10 years2,823 2,833 >10 years1,557 1,555 Total$155,160 $155,489 As of October 31, 2024, the balances of our cash equivalents and short-term investments are as follows:Amortized CostGrossUnrealizedGainsGrossUnrealizedLosses Less Than 12 Continuous MonthsGrossUnrealizedLosses 12 Continuous Months or LongerEstimatedFair Value(1) (in thousands)Cash equivalents:Money market funds$869,972 $— $— $— $869,972 U.S. Treasury, agency & T-bills7,984 1 — — 7,985 Total:$877,956 $1 $— $— $877,957 Short-term investments:U.S. Treasury, agency & T-bills$19,411 $44 $(6)$— $19,449 Corporate debt securities105,024 349 (115)(2)105,256 Asset-backed securities29,061 130 (7)(20)29,164 Total:$153,496 $523 $(128)$(22)$153,869 (1)See Note 9. Fair Value Measurements for further discussion on fair values.Restricted cash. We include amounts generally described as restricted cash in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown in the condensed consolidated statements of cash flows. Restricted cash is primarily associated with office leases and employee loan programs.

12

The following table provides a reconciliation of cash, cash equivalents and restricted cash included in the condensed consolidated balance sheets and the condensed consolidated statements of cash flows:As ofJanuary 31, 2025October 31, 2024(in thousands)Cash